title: Antithrombotic agents in coronary artery disease.
authors.affiliation: Faculty of Medicine, University of British Columbia, Vancouver, Canada.
authors.forename: J A
authors.initials: JA
authors.lastname: Cairns
authors.forename: P
authors.initials: P
authors.lastname: Théroux
authors.forename: H D
authors.initials: HD
authors.lastname: Lewis
authors.forename: M
authors.initials: M
authors.lastname: Ezekowitz
authors.forename: T W
authors.initials: TW
authors.lastname: Meade
authors.forename: G C
authors.initials: GC
authors.lastname: Sutton
mesh_terms: D000789:Angina, Unstable / Q000150:complications*; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D003327:Coronary Disease / Q000150:complications* / Q000517:prevention & control; D003328:Coronary Thrombosis / Q000517:prevention & control; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications* / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011322:Primary Prevention; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D001241:Aspirin